In Case You Missed It: The First CRISPR Clinical Trial, A New Shield for Chernobyl—and More! – Scientific American
|
In Case You Missed It: The First CRISPR Clinical Trial, A New Shield for Chernobyl—and More!
Scientific American The first clinical trial to employ cells edited by the genetic tool CRISPR/Cas9 is now under way in China. Three more are scheduled to begin next month. In all four, humans are injected with modified immune cells that researchers hope will fight … |
|
Cryoport to Support ProMab Biotechnologies’ CAR-T Cell Preclinical …
Yahoo Finance IRVINE, Calif., Jan. 17, 2017 /PRNewswire/ — Cryoport, Inc. (NASDAQ: CYRX, CYRXW) (“Cryoport” or the “Company”), the world’s leading cryogenic logistics … |
Sports Perspectives |
Abeona Therapeutics to Present at Phacilitate Cell & Gene Therapy World 2017
GlobeNewswire (press release) NEW YORK and CLEVELAND, Jan. 17, 2017 (GLOBE NEWSWIRE) — Abeona Therapeutics Inc. (NASDAQ:ABEO) a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening rare genetic diseases, today announced … Abeona Therapeutics Inc. (ABEO) Receives Consensus Recommendation of “Buy” from AnalystsThe Cerbat Gem Abeona Therapeutics Inc. (ABEO) Forecasted to Post FY2016 Earnings of ($0.59) Per ShareSports Perspectives |
Sacramento Bee |
California’s stem cell agency will run out of money in three years. Should voters OK spending more?
Sacramento Bee Scientist Donald Kohn of UCLA cured her of the rare affliction by using her own blood stem cells to alter a troublesome gene. It was an experimental treatment not readily available to the public at large. Kohn’s research has been supported with nearly … |